Evidence map›Paper›PMID 25143950›Full record

ReviewBioMed research international2014

Netrins and their roles in placental angiogenesis.

Mbarka Dakouane-Giudicelli, Nadia Alfaidy, Philippe de Mazancourt

Abstract readReview
In one paragraph

Review in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Hepatic Expression of NTN4 and Its Receptors in Patients with Hepatocellular Carcinoma.Asian Pacific journal of cancer prevention : APJCP · 2023
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mbarka Dakouane-GiudicelliUniversité de Versailles Saint Quentin en Yvelines, Unité Pathologie Cellulaire et Génétique (UPCG) UPRES EA24-93, UFR des Sciences de la Santé, 2 avenue de la Source de la Bièvre, 78180 Montigny le Bretonneux, France.
Nadia AlfaidyUnité Mixte INSERM-UJF-CEA-CNRS U1036, CEA, 17 rue des Martyrs, 38054 Grenoble, France.
Philippe de MazancourtUniversité de Versailles Saint Quentin en Yvelines, Unité Pathologie Cellulaire et Génétique (UPCG) UPRES EA24-93, UFR des Sciences de la Santé, 2 avenue de la Source de la Bièvre, 78180 Montigny le Bretonneux, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Netrins, a family of laminin-related proteins, were originally identified as axonal guidance molecules. Subsequently, netrins were found to modulate various biological processes including morphogenesis, tumorogenesis, adhesion, and, recently, angiogenesis. In human placenta, the most vascularized organ, the presence of netrins has also been reported. Recent studies demonstrated the involvement of netrins in the regulation of placental angiogenesis. In this review we focused on the role of netrins in human placental angiogenesis. Among all netrins examined, netrin-4 and netrin-1 have been found to be either pro- or antiangiogenic factors. These opposite effects appear to be related to the endothelial cell phenotype studied and seem also to depend on the receptor type to which netrin binds, that is, the canonical receptor member of the DCC family, the members of the UNC5 family, or the noncanonical receptor members of the integrin family or DSCAM.

Indexed as

Neovascularization, PhysiologicAnimalsFemaleHumansNerve Growth FactorsPlacentaPregnancyReceptors, Cell SurfaceNerve Growth FactorsReceptors, Cell Surface

Identifiers

PMID25143950
PMCPMC4124232

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.